Moleculin Biotech (MBRX) Institutional Ownership $1.88 +0.14 (+8.05%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$1.92 +0.05 (+2.39%) As of 08:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Moleculin Biotech (NASDAQ:MBRX)CurrentInstitutional OwnershipPercentage15.52%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$41.33MNumber ofInstitutional Sellers(last 12 months)0 Get MBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBRX Institutional Buying and Selling by Quarter Moleculin Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC156,000$549K0.0%+5.1%6.747% 2/13/2024Armistice Capital LLC3,207,417$2.75M0.0%N/A9.600% 1/17/2024Atticus Wealth Management LLC50,001$43K0.0%N/A0.168% 5/15/2023Sio Capital Management LLC1,010,956$971K0.5%-2.5%3.407% 7/25/2022 Walker Asset Management LLC20,708$32K0.0%N/A0.072% 4/20/2022Sigma Planning Corp57,500$102K0.0%+33.7%0.201% 2/2/2022Sigma Planning Corp43,000$80K0.0%N/A0.150% 11/9/2021BlackRock Inc.270,402$812K0.0%-2.5%0.947% 9/17/2021Virtu Financial LLC25,302$93K0.0%N/A0.089% 8/16/2021Occudo Quantitative Strategies LP29,188$107K0.0%+31.7%0.102% Get the Latest News and Ratings for MBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/16/2021State Street Corp59,900$220K0.0%N/A0.210% 8/13/2021Geode Capital Management LLC237,586$871K0.0%+35.9%0.835% 8/13/2021Vanguard Group Inc.1,047,529$3.84M0.0%+123.6%3.683% 8/12/2021XTX Topco Ltd32,997$121K0.0%N/A0.116% 8/5/2021GSA Capital Partners LLP31,120$114K0.0%N/A0.109% 5/21/2021Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/19/2021Squarepoint Ops LLC28,904$118K0.0%+134.2%0.102% 5/18/2021Cubist Systematic Strategies LLC26,624$109K0.0%N/A0.094% 5/18/2021Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/14/2021Occudo Quantitative Strategies LP22,158$90K0.0%N/A0.078% 5/12/2021Northern Trust Corp50,731$207K0.0%-43.1%0.178% 5/12/2021Geode Capital Management LLC174,822$713K0.0%-40.6%0.615% 5/7/2021BlackRock Inc.239,326$977K0.0%+449.7%0.841% 4/27/2021Harel Insurance Investments & Financial Services Ltd.10,000$136K0.0%N/A0.035% 4/14/2021Taylor Cottrill Erickson & Associates Inc.16,964$69K0.0%-83.3%0.060% 2/10/2021Renaissance Technologies LLC948,503$756K0.0%+6.4%7.901% (Data available from 1/1/2016 forward) MBRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Moleculin Biotech shares: Sio Capital Management LLC ($971K), and Armistice Capital LLC ($549K), Atticus Wealth Management LLC ($43K).Learn more on MBRX's institutional investors. What percentage of Moleculin Biotech stock is owned by institutional investors? 15.52% of Moleculin Biotech stock is owned by institutional investors. Learn more on MBRX's institutional investor holdings. Which institutional investors have been buying Moleculin Biotech stock? The following institutional investors have purchased Moleculin Biotech stock in the last 24 months: Armistice Capital LLC ($3.21M), and Atticus Wealth Management LLC ($50.00K). How much institutional buying is happening at Moleculin Biotech? Institutional investors have bought a total of 3,264,923 shares in the last 24 months. This purchase volume represents approximately $41.97M in transactions. Which Moleculin Biotech major shareholders have been selling company stock? The following institutional investors have sold Moleculin Biotech stock in the last 24 months: Sio Capital Management LLC ($25.90K). How much institutional selling is happening at Moleculin Biotech? Institutional investors have sold a total of 25,897 shares in the last 24 months. This volume of shares sold represents approximately $372.92K in transactions. Related Companies CARA Institutional Ownership TENX Institutional Ownership ATHA Institutional Ownership GOVX Institutional Ownership MIRA Institutional Ownership CYTH Institutional Ownership BTAI Institutional Ownership APRE Institutional Ownership BFRG Institutional Ownership CARM Institutional Ownership This page (NASDAQ:MBRX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
